fbpx Skip to main content

Event Archive

August 5, 2020 | Critical Look: Finally, Value-Based Insights Fitting into the Biotech Culture

Biotech companies need to demonstrate the value of their asset(s) in order to optimize their partnerships or have a successful public offering. The market insights required to drive that valuation include a deep understanding of the market landscape, key unmet needs and how other molecules may fulfill those, and what a successful clinical trial design should look like. Shaping your target product profile in light of the external environment is a critical success factor for maximizing the value of your asset and/or company.